Suppr超能文献

肿瘤细胞巢大小和纤维反应联合评估是食管鳞癌的一种优秀预后预测指标。

Combined assessment of tumour cell nest size and desmoplastic reaction as an excellent prognostic predictor in oesophageal squamous cell carcinoma.

机构信息

Department of Pathology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Department of Pathology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.

出版信息

Histopathology. 2022 Jun;80(7):1112-1120. doi: 10.1111/his.14657. Epub 2022 May 5.

Abstract

AIMS

Tumour budding (TB) activity, cell nest size (CNS), and desmoplastic reaction (DR) have been confirmed to be significantly correlated with prognosis in oesophageal squamous cell cancer (ESCC) recently. However, there are limited data on the prognostic significance of combined assessment of cellular dissociation and tumour stroma in ESCC.

METHODS

In all, 265 cases with resected ESCCs diagnosed between January 2018 and August 2019 were retrospectively reviewed. All slides were reviewed for assessing TB, CNS, and DR. The Cellular Dissociation Grading and our Combined CNS and DR (CNS/DR) Grading systems were adopted to re-grade ESCCs.

RESULTS

High TB activity, small CNS, and immature DR had a strong association with shorter overall survival (OS) and progression-free survival (PFS) (P < 0.001, respectively) in ESCC. Combined assessment of CNS and DR in a 4-tiered grading system displayed a prognostic excellence for survival (P < 0.001), and outperformed the Cellular Dissociation Grading for both OS (area under the curve [AUC], 0.728 versus 0.644, P = 0.043) and PFS (AUC, 0.763 versus 0.667, P = 0.018) by receiver operator characteristic curves. Also, Combined CNS/DR Grading showed superiority in recognizing a G4 subgroup with the worst outcome in our cohort, to whom the most urgent attention needs to be called.

CONCLUSIONS

This is the first study to propose a novel Combined Grading system based on CNS and DR in ESCC, which has been demonstrated to be relatively superior to Cellular Dissociation Grading in predicting prognosis. The findings shed new light on the histopathological grading of ESCC and facilitates identifying biologically aggressive ESCCs.

摘要

目的

肿瘤芽(TB)活性、细胞巢大小(CNS)和间质反应(DR)最近已被证实与食管鳞状细胞癌(ESCC)的预后显著相关。然而,关于细胞解离和肿瘤基质联合评估在 ESCC 中的预后意义的数据有限。

方法

回顾性分析 2018 年 1 月至 2019 年 8 月期间诊断的 265 例接受手术治疗的 ESCC 病例。所有切片均用于评估 TB、CNS 和 DR。采用细胞解离分级和我们的联合 CNS 和 DR(CNS/DR)分级系统对 ESCC 进行重新分级。

结果

在 ESCC 中,高 TB 活性、小 CNS 和不成熟的 DR 与较短的总生存期(OS)和无进展生存期(PFS)密切相关(P<0.001)。在 4 级分级系统中联合评估 CNS 和 DR 对生存具有卓越的预后价值(P<0.001),在 OS(曲线下面积 [AUC],0.728 与 0.644,P=0.043)和 PFS(AUC,0.763 与 0.667,P=0.018)方面均优于细胞解离分级。此外,在我们的队列中,联合 CNS/DR 分级在识别预后最差的 G4 亚组方面具有优势,对这些患者需要给予最紧急的关注。

结论

这是第一项提出基于 CNS 和 DR 的 ESCC 新型联合分级系统的研究,该系统在预测预后方面被证明优于细胞解离分级。这些发现为 ESCC 的组织病理学分级提供了新的思路,并有助于识别具有侵袭性生物学行为的 ESCC。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验